H. Evin Gulbahce,
MD, MSCI
Languages Spoken: English
Dr. Gulbahce is a professor of pathology at the University of Utah School of Medicine. She received her MD from Hacettepe University in Ankara, Turkey, and completed a residency in anatomic and clinical pathology and a surgical pathology fellowship at the University of Minnesota. Her research interests include HER2 testing, and breast cancer risk factors, specifically risk factor for basal-like and triple negative cancers.
Specialties
Board Certification and Academic Information
| Academic Departments | Pathology
-
Professor (Clinical) |
| Academic Divisions | Anatomic Pathology |
| Board Certification | American Board of Pathology (Anatomic & Clinical) |
Dr. Gulbahce is a professor of pathology at the University of Utah School of Medicine. She received her MD from Hacettepe University in Ankara, Turkey, and completed a residency in anatomic and clinical pathology and a surgical pathology fellowship at the University of Minnesota. Her research interests include HER2 testing, and breast cancer risk factors, specifically risk factor for basal-like and triple negative cancers.
Academic Locations
Huntsman Cancer Hospital
801-581-2507
Board Certification and Academic Information
| Academic Departments | Pathology
-
Professor (Clinical) |
| Academic Divisions | Anatomic Pathology |
| Board Certification | American Board of Pathology (Anatomic & Clinical) |
Education History
| Graduate Training | University of Utah Clinical Investigation M.S.C.I |
| Residency | University of Minnesota Anatomic and Clinical Pathology Resident |
| Fellowship | University of Minnesota Surgical Pathology Fellow |
| Professional Medical | Hacettepe University School of Medicine Medicine M.D. |
Selected Publications - Journal Articles
Journal Article
- Gulbahce HE, White S, Herget KA, Stoddard G, Camp NJ, Buys SS, Sweeney C (2020). 21-gene recurrence score testing utilization among older women from different races: A population-based study. J Geriatr Oncol, 12(2), 206-211.
- Mahlow J, Goold EA, Jedrzkiewicz J, Gulbahce HE (2020). What to Expect From the New ASCO/CAP Guideline Recommendations for Hormone Receptor Testing in Breast Cancer: A National Reference Laboratory Experience. (Epub ahead of print) Appl Immunohistochem Mol Morphol.
- Lin L, Sirohi D, Coleman JF, Gulbahce HE (2019). American Society of Clinical Oncology/College of American Pathologists 2018 Focused Update of Breast Cancer HER2 FISH Testing GuidelinesResults From a National Reference Laboratory. Am J Clin Pathol, 152(4), 479-485.
Letter
Global Impact
Education History
| Professional Medical | Hacettepe University School of Medicine Medicine M.D. |